Vanguard Group
OPTR

Vanguard Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Vanguard Group’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,719,946
Closed -$34.3M – 3947
2013
Q3 		$34.3M Buy
2,719,946
+124,376
+5% +$1.65M ﹤0.01% 1918
2013
Q2 		$37.6M Buy
+2,595,570
New +$37.8M ﹤0.01% 1805

Vanguard Group's OPTR Position: Q4 2013 in Review

Vanguard Group sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,719,946 shares — an estimated $34.3M sold.

Vanguard Group first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $37.6M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Vanguard Group reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Vanguard Group sold 2,719,946 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $34.3M.
  • Vanguard Group first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Vanguard Group's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $37.6M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.